Key result
Antagonizing pro-inflammatory cytokines emerges as a potential novel therapeutic target for CHF.
This review highlights the role of pro-inflammatory cytokines in heart failure pathogenesis and their potential as therapeutic targets.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for cytokine antagonism in heart failure; prospective trials required before any clinical consideration.
Recent studies have shown that patients with heart failure overexpress a class of biologically active molecules, generically referred to as pro-inflammatory cytokines. This article will review recent clinical and experimental material that suggests that pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), and interleukin-6 (IL-6) may play a role in the pathogenesis of congestive heart failure. In addition, we will review recent studies that suggest that antagonizing cytokines may represent a novel target for heart failure therapy.
No takes yet. Share an insight, caveat, or question.
Dibbs et al. (1999) conducted a review in Heart failure. Antagonizing cytokines was evaluated. Pro-inflammatory cytokines may play a role in the pathogenesis of congestive heart failure, and antagonizing them represents a potential novel therapeutic target.
Synapse has enriched 10 related papers. Consider them for comparative context: